Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

GRISTINA, Valerio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.275
EU - Europa 635
AS - Asia 264
AF - Africa 13
SA - Sud America 10
OC - Oceania 5
Totale 2.202
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.273
IT - Italia 402
SG - Singapore 169
DE - Germania 85
CN - Cina 58
GB - Regno Unito 33
FI - Finlandia 21
IE - Irlanda 20
FR - Francia 12
SE - Svezia 10
CI - Costa d'Avorio 9
NL - Olanda 9
RU - Federazione Russa 9
HK - Hong Kong 8
IN - India 8
RO - Romania 8
BE - Belgio 6
UA - Ucraina 6
AU - Australia 5
EG - Egitto 4
BR - Brasile 3
EE - Estonia 3
PE - Perù 3
PL - Polonia 3
VN - Vietnam 3
CA - Canada 2
CL - Cile 2
ES - Italia 2
IL - Israele 2
IR - Iran 2
JP - Giappone 2
MO - Macao, regione amministrativa speciale della Cina 2
TR - Turchia 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
AT - Austria 1
BG - Bulgaria 1
BO - Bolivia 1
CZ - Repubblica Ceca 1
GE - Georgia 1
HU - Ungheria 1
LK - Sri Lanka 1
MK - Macedonia 1
MY - Malesia 1
PK - Pakistan 1
PT - Portogallo 1
TH - Thailandia 1
Totale 2.202
Salva come PNG Salva come JPEG
Città #
Chandler 185
Fairfield 163
Singapore 146
Ashburn 134
Palermo 77
Seattle 60
Wilmington 59
Rome 58
Woodbridge 56
Cambridge 49
Houston 49
Ann Arbor 47
New York 34
Medford 33
Santa Clara 32
Ludwigshafen am Rhein 21
Princeton 21
Des Moines 19
Lawrence 19
Milan 19
Altamura 18
San Diego 18
Munich 16
Dublin 14
Helsinki 14
Bremen 12
Volla 12
Kitzingen 10
London 10
Milazzo 10
Abidjan 9
Beijing 9
Mascalucia 8
Bologna 7
Lappeenranta 7
Messina 7
Turin 7
Brussels 6
Frankfurt am Main 6
Tappahannock 6
Aversa 5
Dallas 5
Jinan 5
Naples 5
Napoli 5
Pune 5
Redwood City 5
San Paolo di Civitate 5
Verona 5
Cagliari 4
Cairo 4
Changsha 4
Council Bluffs 4
Hong Kong 4
Los Angeles 4
Marsala 4
Melbourne 4
Rimini 4
Agrigento 3
Boardman 3
Catania 3
Guangzhou 3
Kilburn 3
Kumar 3
Lima 3
Tallinn 3
Washington 3
Acton 2
Alexandria 2
Azor 2
Berlin 2
Brzeg 2
Cairate 2
Caronno Pertusella 2
Central 2
Charlottesville 2
Columbus 2
Falls Church 2
Fremont 2
Galway 2
Genoa 2
Giugliano In Campania 2
Hebei 2
Ho Chi Minh City 2
Iowa City 2
Islington 2
Izmir 2
Kaohsiung City 2
L’Aquila 2
Macau 2
Mehlingen 2
Mogi das Cruzes 2
Moscow 2
Nanjing 2
Osio Sotto 2
Romainville 2
Saint Petersburg 2
San Francisco 2
Shanghai 2
Shijiazhuang 2
Totale 1.661
Salva come PNG Salva come JPEG
Nome #
Clinical efficacy of nab-paclitaxel in patients with metastatic pancreatic cancer 156
KRAS mutations testing in non-small cell lung cancer: The role of Liquid biopsy in the basal setting 155
Immuno-targeted combinations in oncogene-addicted non-small cell lung cancer 143
Programmed Death Ligand 1 (PD-L1) as a Predictive Biomarker for Pembrolizumab Therapy in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC) 138
The significance of epidermal growth factor receptor uncommon mutations in non-small cell lung cancer: A systematic review and critical appraisal 96
Non-Small Cell Lung Cancer Harboring Concurrent EGFR Genomic Alterations: A Systematic Review and Critical Appraisal of the Double Dilemma 94
Analysis of systemic inflammatory biomarkers in neuroendocrine carcinomas of the lung: prognostic and predictive significance of NLR, LDH, ALI, and LIPI score 93
Is there any place for PD-1/CTLA-4 inhibitors combination in the first-line treatment of advanced NSCLC?—A trial-level meta-analysis in PD-L1 selected subgroups 90
Moving the target on the optimal adjuvant strategy for resected pancreatic cancers: A systematic review with meta-analysis 88
The emerging therapeutic landscape of alk inhibitors in non-small cell lung cancer 76
Diabetes and cancer: A critical appraisal of the pathogenetic and therapeutic links 68
Can the plasma PD-1 levels predict the presence and efficiency of tumor-infiltrating lymphocytes in metastatic melanoma patients? 63
A narrative review on the implementation of liquid biopsy as a diagnostic tool in thoracic tumors during the COVID-19 pandemic 58
Safety and effectiveness of gemcitabine for the treatment of classic Kaposi’s sarcoma without visceral involvement 54
The diagnostic accuracy of PIK3CA mutations by circulating tumor DNA in breast cancer: an individual patient data meta-analysis 53
Cancer of the Thyroid 53
Clinical Potential of Circulating Cell-Free DNA (cfDNA) for Longitudinally Monitoring Clinical Outcomes in the First-Line Setting of Non-Small-Cell Lung Cancer (NSCLC): A Real-World Prospective Study 52
Prognostic role of soluble PD-1 and BTN2A1 in overweight melanoma patients treated with nivolumab or pembrolizumab: finding the missing links in the symbiotic immune-metabolic interplay 52
Tumor mutational burden on cytological samples: A pilot study 51
The prognostic impact of tumor mutational burden (TMB) in the first-line management of advanced non-oncogene addicted non-small-cell lung cancer (NSCLC): a systematic review and meta-analysis of randomized controlled trials 47
The molecular profiling of solid tumors by liquid biopsy: a position paper of the AIOM–SIAPEC-IAP–SIBioC–SIC–SIF Italian Scientific Societies 42
Is there any room for PD-1 inhibitors in combination with platinum-based chemotherapy as frontline treatment of extensive-stage small cell lung cancer? A systematic review and meta-analysis with indirect comparisons among subgroups and landmark survival analyses 41
Theranostic biomarkers and PARP-inhibitors effectiveness in patients with non-BRCA associated homologous recombination deficient tumors: Still looking through a dirty glass window? 39
Implementation of preventive and predictive BRCA testing in patients with breast, ovarian, pancreatic, and prostate cancer: a position paper of Italian Scientific Societies 38
TargetPlex FFPE-Direct DNA Library Preparation Kit for SiRe NGS panel: An international performance evaluation study 36
Moving Immune Checkpoint Inhibitors to Early Non-Small Cell Lung Cancer: A Narrative Review 35
KIT/PDGFRA Variant Allele Frequency as Prognostic Factor in Gastrointestinal Stromal Tumors (GISTs): Results From a Multi-Institutional Cohort Study 34
Molecular tumor board 34
Exploring the potential of multiomics liquid biopsy testing in the clinical setting of lung cancer 33
Navigating the liquid biopsy Minimal Residual Disease (MRD) in non-small cell lung cancer: Making the invisible visible 33
Current clinically validated applications of liquid biopsy 31
Body mass index and baseline platelet count as predictive factors in Merkel cell carcinoma patients treated with avelumab 30
Exploring the Dynamic Crosstalk between the Immune System and Genetics in Gastrointestinal Stromal Tumors 29
Circulating cell-free DNA (cfDNA) and extracellular vesicles (EVs) as prognostic and predictive biomarkers in patients with advanced Non-Small Cell Lung Cancer (NSCLC): the LEXOVE prospective study 28
The significance of tissue-agnostic biomarkers in solid tumors: the more the merrier? 27
Extracellular Vesicles-ceRNAs as Ovarian Cancer Biomarkers: Looking into circRNA-miRNA-mRNA Code 25
Roles of Tumor-Educated Platelets (TEPs) in the biology of Non-Small Cell Lung Cancer (NSCLC): A systematic review. “Re-discovering the neglected biosources of the liquid biopsy family” 24
The role of bone modifying agents for secondary osteoporosis prevention and pain control in post-menopausal osteopenic breast cancer patients undergoing adjuvant aromatase inhibitors 23
Next generation diagnostic algorithm in non-small cell lung cancer predictive molecular pathology: The KWAY Italian multicenter cost evaluation study 22
Dissecting the nuances of cancer epigenomics in liquid biopsy 22
On-treatment dynamics of circulating extracellular vesicles in the first-line setting of patients with advanced non-small cell lung cancer: the LEXOVE prospective study. 22
Immunological Aspects of Von Hippel-Lindau Disease: A Focus on Neuro-Oncology and Myasthenia Gravis 21
Network approach in liquidomics landscape 20
Liquid biopsy and immunotherapy: is all that glitter gold? 19
Extracellular Vesicles in Lung Cancer: Implementation in Diagnosis and Therapeutic Perspectives 19
The intersection of homologous recombination (HR) and mismatch repair (MMR) pathways in DNA repair-defective tumors 19
Clinical utility of ctDNA by amplicon based next generation sequencing in first line non small cell lung cancer patients 17
Anthracycline-related cardiotoxicity in patients with breast cancer harboring mutational signature of homologous recombination deficiency (HRD) 16
Early detection screening: myth or reality? 14
Consolidative thoracic radiation therapy for extensive-stage small cell lung cancer in the era of first-line chemoimmunotherapy: preclinical data and a retrospective study in Southern Italy 13
Polθ: emerging synthetic lethal partner in homologous recombination-deficient tumors 12
Future perspectives 12
Liquid biopsy: a right tool in a right context? 11
Applications of Platelet Concentrates (PCs) in Regenerative Onco-Urology: A Systematic Review of Literature 9
Totale 2.530
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.096
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.096
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020149 0 0 0 0 0 13 9 6 30 56 30 5
2020/2021336 7 17 14 56 48 36 13 43 26 27 22 27
2021/2022409 62 54 15 9 13 35 18 13 25 49 62 54
2022/2023556 45 91 13 75 39 82 30 64 47 9 44 17
2023/2024494 10 40 28 43 44 81 68 75 19 21 5 60
2024/2025536 66 94 95 110 78 93 0 0 0 0 0 0
Totale 2.530